V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260008680 | 260005767 | 1.9 | null | Disease modification (D) | 2016-12-06 | 2016-12-29 | Rituximab | N | N | 260028391 | BEAM |
| 260008681 | 260005767 | 1.49 | 55.4 | null | 2016-12-02 | 2016-12-02 | PMitCEBO | 2 | N | 260028391 | OXALIPLATIN + MDG |
| 260008682 | 260005768 | 1.78 | null | Adjuvant (A) | 2016-03-22 | 2016-04-02 | Rituximab | 2 | N | 260028395 | BEAM |
| 260008683 | 260005768 | 1.73 | 70.2 | Palliative (P) | 2014-12-27 | 2015-01-05 | Rituximab | N | N | 260028395 | NOT MATCHED |
| 260008684 | 260005768 | 1.73 | 74 | Palliative (P) | 2017-09-15 | 2017-09-16 | null | N | N | 260028395 | RITUXIMAB |
| 260008685 | 260005769 | 1.67 | 65.8 | Palliative (P) | 2013-10-06 | 2013-10-20 | Rituximab | 02 | N | 260028399 | BENDAMUSTINE |
| 260008686 | 260005769 | 1.85 | 89.9 | Palliative (P) | 2013-10-31 | 2013-12-16 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 260028399 | RITUXIMAB |
| 260008687 | 260005769 | 1.74 | 94.2 | Curative (C) | 2017-03-23 | 2017-03-23 | ESHAP R | 02 | null | 260028399 | BENDAMUSTINE |
| 260008688 | 260005769 | 1.75 | 70.6 | Palliative (P) | 2018-07-05 | 2018-07-14 | Rituximab | Y | N | 260028399 | CHOP |
| 260008689 | 260005770 | null | null | Palliative (P) | 2015-09-22 | 2015-09-22 | Rituximab | null | N | 260028405 | RITUXIMAB |
| 260008690 | 260012000 | null | 56 | Not known (9) | 2017-09-17 | 2017-09-17 | Rituximab | null | null | 260028408 | RITUXIMAB |
| 260008691 | 260012000 | 1.67 | 77 | Adjuvant (A) | 2014-05-30 | 2014-06-01 | CYCLO + RITUXIMAB + VINCRISTINE | 02 | N | 260028408 | BORTEZOMIB + THALIDOMIDE |
| 260008692 | 260012000 | 1.7 | 51 | Disease modification (D) | 2017-12-05 | 2017-12-05 | REMODLB TRIAL | 99 | null | 260028408 | RITUXIMAB |
| 260008693 | 260005771 | 1.83 | 107.7 | Neo-adjuvant (N) | null | 2016-05-11 | RCEOP | N | N | 260028418 | RITUXIMAB |
| 260008694 | 260005771 | 1.65 | null | Curative (C) | 2017-06-07 | 2017-06-20 | PACIFICO TRIAL | 2 | null | 260028418 | RITUXIMAB |
| 260008695 | 260005772 | 1.68 | null | Curative (C) | 2016-07-24 | 2016-07-25 | Rituximab (Maintenance) | 02 | N | 260028421 | RITUXIMAB |
| 260008696 | 260005772 | 1.74 | 130 | Curative (C) | 2016-03-24 | 2016-04-22 | RCEOP | null | N | 260028421 | RITUXIMAB |
| 260008697 | 260005773 | 1.75 | 62.7 | Palliative (P) | 2015-09-22 | 2015-10-18 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + ETOPOSIDE + VINCRISTINE | 02 | N | 260028425 | RITUXIMAB |
| 260008698 | 260005773 | 1.71 | 61.2 | Palliative (P) | 2014-01-27 | 2014-01-27 | Rituximab | N | N | 260028425 | CHLORAMBUCIL + RITUXIMAB |
| 260008699 | 260005773 | 1.8 | 87 | Curative (C) | 2013-01-15 | 2013-01-18 | Rituximab | 02 | N | 260028425 | IRINOTECAN + MDG |
| 260008700 | 260005774 | null | 70.9 | Palliative (P) | 2014-07-29 | 2014-07-29 | CISPLATIN + ETOPOSIDE | 02 | N | 260028430 | CARBOPLATIN + ETOPOSIDE |
| 260008701 | 260005775 | 1.66 | 94.3 | Palliative (P) | null | 2014-10-20 | PACIFICO TRIAL | Y | N | 260028436 | CAPECITABINE + GEMCITABINE |
| 260008702 | 260012004 | 1.58 | null | Palliative (P) | 2013-03-01 | 2013-03-15 | FCR | N | N | 260028439 | NOT MATCHED |
| 260008703 | 260005776 | 1.89 | 114.5 | Curative (C) | 2013-02-28 | 2013-02-28 | Rituximab | N | N | 260028440 | ABVD |
| 260008704 | 260012005 | null | 74.8 | Curative (C) | 2013-06-24 | 2013-06-27 | IMATINIB | N | N | 260028442 | RITUXIMAB |
| 260008707 | 260015557 | 1.79 | 90.1 | Not known (9) | 2017-08-28 | 2017-09-04 | Chlorambucil | 02 | N | 260028450 | GALLIUM TRIAL |
| 260008708 | 260015557 | 1.59 | null | Adjuvant (A) | 2016-02-05 | 2016-02-08 | ETOPOSIDE | N | N | 260028450 | RITUXIMAB |
| 260008709 | 260005778 | null | 66 | Disease modification (D) | 2014-03-18 | 2014-03-25 | INTERFERON | 02 | N | 260028452 | GALLIUM TRIAL |
| 260008710 | 260005779 | null | 80.3 | null | 2016-03-19 | 2016-03-28 | Bendamustine + prednisolone | N | N | 260028453 | RITUXIMAB |
| 260008711 | 260005779 | null | 98 | Palliative (P) | 2015-06-21 | 2015-06-28 | CARBOPLATIN + ETOPOSIDE | 02 | N | 260028453 | CISPLATIN + ETOPOSIDE |
| 260008712 | 260005780 | 1.75 | 52 | Disease modification (D) | 2018-06-16 | 2018-06-28 | BENDAMUSTINE | 2 | N | 260028457 | CHLORAMBUCIL |
| 260008713 | 260005781 | null | 71.6 | Palliative (P) | 2014-11-08 | 2014-11-25 | ETOPOSIDE | 02 | N | 260028458 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260008714 | 260005781 | 1.74 | 70 | Palliative (P) | 2016-11-26 | 2016-11-27 | null | N | null | 260028458 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE |
| 260008715 | 260005782 | 1.74 | null | null | 2017-08-24 | 2017-08-28 | Carboplatin + Etoposide iv&po | 2 | N | 260028463 | CLADRIBINE |
| 260008716 | 260005783 | 1.62 | 82 | Disease modification (D) | 2016-05-02 | 2016-05-27 | Rituximab | Y | N | 260028467 | R-EPOCH |
| 260008717 | 260012009 | 1.67 | 67.7 | Curative (C) | 2015-05-30 | 2015-05-30 | CHLORAMBUCIL + RITUXIMAB | 2 | Y | 260028470 | RITUXIMAB |
| 260008718 | 260005784 | 1.78 | 73 | Curative (C) | 2013-08-27 | 2013-08-28 | PACIFICO TRIAL | 02 | null | 260028472 | RITUXIMAB |
| 260008719 | 260005784 | 1.85 | null | Palliative (P) | 2017-10-28 | 2017-11-16 | Capecitabine + Cisplatin | N | N | 260028472 | PACIFICO TRIAL |
| 260008720 | 260005785 | 1.8 | 96.2 | Curative (C) | 2016-09-15 | 2016-09-29 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + FILGRASTIM + METHOTREXATE | N | N | 260028474 | NOT MATCHED |
| 260008721 | 260005785 | 1.7 | 66 | Curative (C) | 2016-11-06 | 2016-11-06 | Mitomycin Intravesical | 99 | null | 260028474 | RITUXIMAB |
| 260008722 | 260005786 | 1.64 | 90.4 | Palliative (P) | 2016-05-01 | 2016-05-01 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 260028482 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260008723 | 260012012 | 1.79 | 88.4 | Curative (C) | 2015-04-17 | 2015-05-04 | CISPLATIN + ETOPOSIDE | N | N | 260028483 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260008724 | 260012012 | null | 62 | Curative (C) | 2017-02-13 | 2017-02-20 | CHLORAMBUCIL + RITUXIMAB | N | N | 260028483 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260008725 | 260005787 | 1.62 | null | Adjuvant (A) | 2016-07-29 | 2016-07-30 | CARBOPLATIN + PACLITAXEL | N | N | 260028487 | RITUXIMAB |
| 260008726 | 260012013 | 1.84 | null | Curative (C) | 2013-09-12 | 2013-09-16 | PACIFICO TRIAL | 2 | N | 260028489 | CHOP |
| 260008727 | 260005788 | 1.88 | 60 | Curative (C) | 2015-06-20 | 2015-06-21 | ESHAP R | 02 | N | 260028491 | FCR |
| 260008728 | 260005789 | 0 | 110.7 | Disease modification (D) | 2016-09-16 | 2016-09-22 | Capecitabine + Oxaliplatin 21day | 2 | N | 260028493 | DOCETAXEL |
| 260008729 | 260012014 | 1.76 | 99.6 | null | null | 2017-12-14 | RCEOP | null | null | 260028494 | RITUXIMAB |
| 260008730 | 260005790 | 1.79 | 66 | Disease modification (D) | 2017-05-19 | 2017-06-10 | Cytarabine HD + Methotrexate HD | 02 | N | 260028497 | BENDAMUSTINE |
| 260008731 | 260005790 | 1.64 | 71.9 | Curative (C) | 2017-04-01 | 2017-05-10 | Trial Unspecified | N | N | 260028497 | BEAM |